Invention Grant
- Patent Title: NKp46 binding agents
-
Application No.: US16478863Application Date: 2018-01-22
-
Publication No.: US11377492B2Publication Date: 2022-07-05
- Inventor: Nadia Anceriz , Mathieu Blery , Laurent Gauthier , Carine Paturel
- Applicant: INNATE PHARMA
- Applicant Address: FR Marseilles
- Assignee: INNATE PHARMA
- Current Assignee: INNATE PHARMA
- Current Assignee Address: FR Marseilles
- Agency: Saliwanchik, Lloyd & Eisenschenk
- International Application: PCT/EP2018/051394 WO 20180122
- International Announcement: WO2018/138032 WO 20180802
- Main IPC: C07K16/30
- IPC: C07K16/30 ; A61P35/00 ; C07K16/28 ; A61K47/68 ; G01N33/569
Abstract:
The present invention provides antigen-binding proteins capable of binding to NKp46 polypeptides. The antigen-binding proteins have increased activity in the treatment of disorders characterized by NKp46-expressing cells, particularly tumor cells.
Information query
